CCR5 Expression Levels Influence NFAT Translocation, IL-2 Production, and Subsequent Signaling Events during T Lymphocyte Activation

被引:71
作者
Camargo, Jose F. [1 ,2 ]
Quinones, Marlon P. [1 ,2 ,3 ,4 ]
Mummidi, Srinivas [1 ,2 ]
Srinivas, Sowmya [1 ,2 ]
Gaitan, Alvaro A. [1 ,2 ]
Begum, Kazi [1 ,2 ]
Jimenez, Fabio [1 ,2 ]
VanCompernolle, Scott [5 ]
Unutmaz, Derya [6 ]
Ahuja, Seema S. [1 ,2 ]
Ahuja, Sunil K. [1 ,2 ,7 ,8 ,9 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
[2] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV1 Infect, San Antonio, TX USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA
[4] Univ Texas Hlth Sci Ctr San Antonio, Ctr Bipolar Illness Intervent Hispan Communities, San Antonio, TX 78229 USA
[5] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37201 USA
[6] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA
[7] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol, San Antonio, TX 78229 USA
[8] Univ Texas Hlth Sci Ctr San Antonio, Dept Immunol, San Antonio, TX 78229 USA
[9] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA
基金
美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CCR5; CELL-MEDIATED-IMMUNITY; BETA-CHEMOKINES; HIV-1; INFECTION; CHEMOTACTIC RESPONSIVENESS; RHEUMATOID-ARTHRITIS; ALLOGRAFT-REJECTION; AIDS PATHOGENESIS; KAWASAKI-DISEASE;
D O I
10.4049/jimmunol.182.1.171
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ligands of CCR5, the major coreceptor of HIV-1, costimulate T lymphocyte activation. However, the full impact of CCR5 expression on T cell responses remains unknown. Here, we show that compared with CCR5(+/+), T cells from CCR5(-/-) mice secrete lower amounts of IL-2, and a similar phenotype is observed in humans who lack CCR5 expression (CCR5-Delta 32/Delta 32 homozygotes) as well as after Ab-mediated blockade of CCR5 in human T cells genetically intact for CCR5 expression. Conversely, overexpression of CCR5 in human T cells results in enhanced IL-2 production. CCR5 surface levels correlate positively with IL-2 protein and mRNA abundance, suggesting that CCR5 affects IL-2 gene regulation. Signaling via CCR5 resulted in NFAT transactivation in T cells that was blocked by Abs against CCR5 agonists, suggesting a link between CCR5 and downstream pathways that influence IL-2 expression. Furthermore, murine T cells lacking CCR5 had reduced levels of intranuclear NFAT following activation. Accordingly, CCR5 expression also promoted IL-2-dependent events, including CD25 expression, STAT5 phosphorylation, and T cell proliferation. We therefore suggest that by influencing a NFAT-mediated pathway that regulates IL-2 production and IL-2-dependent events, CCR5 may play a critical role in T cell responses. In accord with our prior inferences from genetic-epidemiologic studies, such CCR5-dependent responses might constitute a viral entry-independent mechanism by which CCR5 may influence HIV-AIDS pathogenesis. The Journal of Immunology, 2009, 182: 171-182.
引用
收藏
页码:171 / 182
页数:12
相关论文
共 92 条
[1]   The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection [J].
Abdi, R ;
Smith, RN ;
Makhlouf, L ;
Najafian, N ;
Luster, AD ;
Auchincloss, H ;
Sayegh, MH .
DIABETES, 2002, 51 (08) :2489-2495
[2]   A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection [J].
Akashi, S ;
Sho, M ;
Kashizuka, H ;
Hamada, K ;
Ikeda, N ;
Kuzumoto, Y ;
Tsurui, Y ;
Nomi, T ;
Mizuno, T ;
Kanehiro, H ;
Hisanaga, M ;
Ko, S ;
Nakajima, Y .
TRANSPLANTATION, 2005, 80 (03) :378-384
[3]   CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells [J].
Algeciras-Schimnich, A ;
Vlahakis, SR ;
Villasis-Keever, A ;
Gomez, T ;
Heppelmann, CJ ;
Bou, G ;
Paya, CV .
AIDS, 2002, 16 (11) :1467-1478
[4]  
Asselin S, 1998, EUR J IMMUNOL, V28, P532, DOI 10.1002/(SICI)1521-4141(199802)28:02<532::AID-IMMU532>3.0.CO
[5]  
2-U
[6]   Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1 [J].
Baba, M ;
Miyake, H ;
Okamoto, M ;
Iizawa, Y ;
Okonogi, K .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (10) :935-941
[7]   ACTIVATION OF DUAL T-CELL SIGNALING PATHWAYS BY THE CHEMOKINE RANTES [J].
BACON, KB ;
PREMACK, BA ;
GARDNER, P ;
SCHALL, TJ .
SCIENCE, 1995, 269 (5231) :1727-1730
[8]   Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies [J].
Blanpain, C ;
Vanderwinden, JM ;
Cihak, J ;
Wittamer, V ;
Le Poul, E ;
Issafras, H ;
Stangassinger, M ;
Vassart, G ;
Marullo, S ;
Schlöndorff, D ;
Parmentier, M ;
Mack, M .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (02) :723-737
[9]   Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation [J].
Blumberg, Hal ;
Dinh, Huyen ;
Trueblood, Esther S. ;
Pretorius, James ;
Kugler, David ;
Weng, Ning ;
Kanaly, Suzanne T. ;
Towne, Jennifer E. ;
Willis, Cynthia R. ;
Kuechle, Melanie K. ;
Sims, John E. ;
Peschon, Jacques J. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (11) :2603-2614
[10]   Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s [J].
Bonecchi, R ;
Bianchi, G ;
Bordignon, PP ;
D'Ambrosio, D ;
Lang, R ;
Borsatti, A ;
Sozzani, S ;
Allavena, P ;
Gray, PA ;
Mantovani, A ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :129-134